Cel-Sci Overview
Latest P/E ratio for Cel-Sci: -0.33 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-0.33
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for CVM is -0.33. That is below the Healthcare sector average of 27.22. Investors often review this figure alongside Cel-Sci's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, CVM currently prints -0.33 for P/E ratio, while the sector average sits near 27.22. That is roughly 101.2% below the sector mean. Large gaps often invite a closer look at Cel-Sci's growth, margins, and balance sheet.
A P/E ratio of -0.33 for Cel-Sci is not 'good' or 'bad' on its own. Compare it with the peer average (27.22) and with CVM's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting CVM's P/E ratio (-0.33), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Cel-Sci's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
